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The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor that binds to xenobiotics and responds by regu-
lating the expression of gene programs required for detoxification andmetabolism. AHR and its heterodimerization partner aryl
hydrocarbon receptor nuclear translocator (ARNT) belong to the basic helix-loop-helix (bHLH)–PER-ARNT-SIM (PAS) family
of transcription factors. Here we report the 2.55-Å-resolution crystal structure of the mouse AHR PAS-A domain, which repre-
sents the first AHR-derived protein structure. The AHR PAS-A domain forms a helix-swapped homodimer in the crystal and also
in solution. Through a detailed mutational analysis of all interface residues, we identified several hydrophobic residues that are
important for AHR dimerization and function. Our crystallographic visualization of AHR PAS-A dimerization leads us to pro-
pose a mode of heterodimerization with ARNT that is supported by both biochemical and cell-based data. Our studies also high-
light the residues of other mammalian bHLH-PAS proteins that are likely involved in their homo- or heterodimerization.
The PER-ARNT-SIM (PAS) domains, originally identified bysequence homology in the Drosophila melanogaster proteins
period and single-minded (encoded by the genes per and sim,
respectively), as well as the vertebrate protein aryl hydrocarbon
receptor nuclear translocator (ARNT), are conserved motifs that
function as sensors and interaction modules in a variety of pro-
teins (1, 2). A subgroup of PAS domain proteins belong to the
basic helix-loop-helix (bHLH) family (3). These bHLH-PAS tran-
scription factors usually contain the bHLHDNA binding domain
(also involved in dimerization) at their N-terminal regions and
tandemly positioned PAS domains (PAS-A and PAS-B), followed
by a transactivation or transrepression domain at their C-terminal
regions (3). The aryl hydrocarbon receptor (AHR) and ARNT are
bothmembers of this family. In AHR, both PAS domains are used
for heterodimerization with ARNT; meanwhile, the PAS-B do-
main also serves as the ligand binding domain (LBD) (4).
Since the 1970s, AHR has been known to be a mediator for the
toxicities of environmental pollutants, including 2,3,7,8-tetrachlo-
rodibenzo-p-dioxin (TCDD). The ligand-bound AHR:ARNT het-
erodimer recognizes and initiates transcription from xenobiotic re-
sponse elements (XREs) of target genes typified by the xenobiotic
metabolizing enzymes like cytochrome P450 1A1 (3). Another target
gene encodes the bHLH-PAS protein aryl hydrocarbon receptor re-
pressor (AHRR) (5), which represses the transcriptional activity of
AHRbyheterodimerizingwithARNTandbinding to theXRE. Some
intrinsic physiological roles ofAHRhave also been revealed by recent
studies. For example, AHR can function as a ligand-dependent E3
ubiquitin ligase targeting sex steroid receptors (6), control regulatory
T (Treg) and interleukin 17 (IL-17)-producingT (TH17) cell differen-
tiation (7, 8), promote tumor cell survival and motility when acti-
vated by the endogenous ligand kynurenine (9), maintain intraepi-
thelial lymphocyte (IEL) numbers (10), and regulate organogenesis
of intestinal lymphoid follicles (11).
Based on the choice of dimerization partners, the bHLH-PAS
proteins have been divided into two classes (2, 3). Class I (class )
members can form heterodimers only with a class II (class )
protein, while class II members can promiscuously form ho-
modimers or can form heterodimers with a partner from class I.
Aside from AHR and AHRR, other mammalian class I members
involved in different functions are three hypoxia-inducible factors
(HIF-1, HIF-2, and HIF-3), which activate the transcription
of target genes critical for survival under low-oxygen conditions
(2, 3); SIM1 and SIM2, homologues of the Drosophila protein
single-minded, which function as transcriptional repressors in
embryogenesis (12); CLOCK and its paralog NPAS2 (neuronal
PAS domain protein 2), the major transcriptional regulators of
circadian rhythm (2, 13); NPAS1, which acts as a transcriptional
repressor by dimerizing with ARNT or ARNT2 and functions in
neuronal differentiation (14); NPAS3, a potential repressor which
downregulates multiple hypoxia-related genes when overex-
pressed in HEK 293 cells (15); and NPAS4, an activity-dependent
transcription factor required for contextual memory formation
(16). Mammalian class II bHLH-PAS proteins include ARNT,
ARNT2, BMAL1 (brain and muscle ARNT-like protein 1, also
known as ARNTL1), and BMAL2 (ARNTL2).
The first characterized mammalian bHLH-PAS protein archi-
tectures were the PAS-B domains derived from human HIF-2
(17) and ARNT (18). Those studies revealed a -sheet interface
used for PAS-B dimerization. The structure determinate of the
HIF-2:ARNT PAS-B complex confirmed this dimerization sur-
face and further revealed how the HIF-2 PAS-B domain binds to
synthetic small-molecule ligands that modulate the dimerization
of the heterodimer (19, 20).More recently, the crystal structure of
the mouse CLOCK:BMAL1 complex illustrated the multifaceted
interactions between the bHLH, PAS-A, and PAS-B domains (21).
However, only one residue from PAS-A domains (Ile317 of
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BMAL1) was identified to be critical for the heterodimerization
and transactivation function of this complex (21).
Besides the CLOCK:BMAL1 complex, no other mammalian
bHLH-PASheterodimeric structures are available to suggesthowthe
AHR:ARNTheterodimermay be forming its intermolecular interac-
tions through the PAS domains. Hao et al. identified several residues
used for dimerization in the PAS-A domains of ARNT and AHR
through a two-hybrid approach (22), finding that ARNT and AHR
interact through equivalent regions of their PAS-Adomains. Todate,
no structure has been available for anyAHRprotein segment, despite
the intense interest in thephysiological functionsof this transcription
factor. Here, we present the crystal structure of the AHR PAS-A do-
main and through a combination of solution- and cell-based studies
further reveal the basis for reciprocal AHR:ARNT heterodimeriza-
tion interactions through their PAS-A domains.
MATERIALS AND METHODS
Plasmid construction and site-directed mutagenesis. For the overex-
pression of the mouse AHR (mAHR) PAS-A domain protein with a 6His
tag inEscherichia coli, aDNA fragment encoding residues 110 to 267 (mAHR
110–267) was cloned into the vector pSJ2 (derived frompET, a generous gift
fromJianWuat theUniversityofMichigan).A similar strategywas applied to
the cloning of mAHR residues 7 to 267 (mAHR 7–267) into pSJ2 and a
fragment encoding mouse ARNT residues 82 to 346 (mARNT 82–346) into
pMKH (no tag; a gift fromWeizhi Liu at Yale University). For the transacti-
vation assays and coimmunoprecipitation (co-IP) experiments, full-length
mAHR and mARNT were cloned into the pCMV-Tag4 and pCMV-Tag1
vectors with a C-terminal Flag tag and Myc tag, respectively. Site-directed
mutagenesis for both mAHR and mARNT was performed as described pre-
viously (23) and confirmed by DNA sequencing. To generate the deletion
mutantA= (110-119),mAHRDNAwasPCRamplifiedas two fragments
(with the first fragment ending atGln108 and the second starting at Asn121),
digested, and ligated together through theHindIII site (AAGCTT),whichwas
positioned on both fragments and finally mutated to GATCTT to encode
Asp109 and Leu120.
Protein expression, purification, and crystallization. The recombi-
nant plasmid pSJ2-mAHR 110-267 was transformed into BL21-Codon-
Plus (DE3)-RIL competent cells (Agilent Technologies) for expression.
After purification by His·Bind resin (Novagen), the protein sample was
concentrated and loaded on a Superdex 200pg (GE Healthcare) gel filtra-
tion column using 20 mM Tris (pH 8.0)–150 mM NaCl as the running
buffer. Protein crystals of mAHR 110-267 were grown at 4°C in sitting
drops equilibrated versus the reservoir solution, which consisted of 100
mM HEPES (pH 7.5), 1.6 M (NH4)2SO4, and 2% polyethylene glycol
(PEG) 1000. Crystals reached the maximum size about 3 months after
setup andwere soaked in cryoprotectant solution containing 30%glycerol
before flash freezing in liquid nitrogen.
X-ray data collection, structure determination and refinement.Dif-
fraction data were collected at the Argonne National Laboratory SBC-
CAT 19ID beamline at a single wavelength of 0.9793 Å at 100 K and
diffracted up to 2.55 Å. The data set was indexed and processed using the
HKL3000 software program (24). The structure was solved by molecular
replacement (MR) using the program Phaser (25) in the CCP4 (26) pro-
gram suite 6.2.0, using PAS-A domain structures from three coordinates,
2VLG (27), 3RTY (28), and 3GEC (29), as the combined search model.
Further model building was facilitated by using Coot (30), and structure
refinement was performed using the programs Refmac5 (31) and phe-
nix.refine (32). Residues 180 to 205 and 245 to 252 are disordered with no
visible electron density map in chain A, as are residues 177 to 206, 223 to
226, and 240 to 253 in chain B. All the structural figures were prepared
using the software program PyMOL (PyMOL Molecular Graphics Sys-
tem, version 1.3; Schrödinger, LLC).
Gel filtration chromatography. After purification by using His·Bind
resin, 2.5 ml of mAHR 110–267 (wild type [WT], A=, or other point
mutants) protein samples were loaded on the Superdex 200pg gel filtra-
tion column using 20 mM Tris (pH 8.0)–150 mM NaCl as the running
buffer at 1.5ml/min. The concentrations of injected samples were 8 to 120
M for the WT, 120 M for the A=mutant, and about 80 M for the
other point mutants. The marker proteins albumin (66 kDa), carbonic
anhydrase (29 kDa), and cytochrome c (12.4 kDa)were dissolved in 2.5ml
running buffer and injected into the column in the same way to serve as
calibration standards.
Ni affinity pulldown. The recombinant plasmid pSJ2-mAHR 7-267
(WT or A=) was transformed alone or cotransformed with pMKH-
mARNT 82-346 into BL21 E. coli cells. After sonication and high-speed
spinning, the cell lysate was loaded onto His·Bind resin, washed with
buffer containing 30 mM imidazole, and then eluted with 300 mM imi-
dazole buffer. The elution samples were finally analyzed by SDS-PAGE
and gel staining.
Transactivation assay (XRE luciferase reporter assay).Murine hep-
atoma Tao cells and HEK 293T cells were grown in minimal essential
medium (MEM) alpha andDulbecco’smodified Eaglemedium (DMEM)
supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-
streptomycin (Gibco, Life Technologies), respectively. For the luciferase
assay testing the AHRWT andmutants, cells were seeded in 24-well plates
and 1 day later transfected with 200 ng of pCMV-Tag4-mAHR (full-
length WT, mutants, or empty plasmid), 400 ng of XRE reporter (con-
taining theXRE1 sequence of the ratCyp1a1 gene promoter region1029
to997), and 5 ng of pRL (control Renilla luciferase) using 1.2 l jetPEI
reagent (Polyplus transfection) for each well according to the manufac-
turer’s protocol. For the luciferase assay testing the ARNT WT and mu-
tants, 293T cells were seeded in the same way and cotransfected with 100
ng of pCMV-Tag4-mAHR WT, 250 ng of pCMV-Tag1-mARNT (WT,
mutants, or empty plasmid), 250 ng of XRE reporter, and 2 ng of pRLwith
1.2 l jetPEI for each well. The medium was refreshed with dimethyl
sulfoxide (DMSO) or 10 nM TCDD after overnight transfection, lucifer-
ase activity was measured another 24 h later using the Dual-Glo luciferase
assay system (Promega E2920), and data were normalized by the relative
ratio of firefly and Renilla luciferase activity.
Coimmunoprecipitation. HEK293T cells were seeded in 10-cm
dishes and 2 days later transfected by using 2 g pCMV-Tag4-mAHR
(WT or mutants) and 6 g pCMV-Tag1-mARNT (WT or mutants) with
16 l jetPRIME reagent (Polyplus transfection), following the manufac-
turer’s protocol. After overnight incubation, medium was refreshed with
DMSOor 10 nMTCDD.Twenty-four hours later, the cells were harvested
and shortly sonicated in 500l lysis buffer (1Tris-buffered saline [TBS]
with 1 mM EDTA, 1% Triton X-100, and 1 protease inhibitor cocktail
[Roche 13744100]) before 10 min of spinning at 12,000g. The protein
concentration in the supernatantwasmeasured using the Bio-Rad protein
assay kit (500-0002). For each sample, 40 g of supernatant was saved as
input for Western blots using the monoclonal antibody [MAb] anti-Flag
M2 (F1804, 1:1,000 dilution; Sigma) or c-Myc antibody (9E10, sc-40
horseradish peroxidase [HRP], 1:400 dilution; Santa Cruz Biotechnol-
ogy). Each immunoprecipitationwas performedwith 1mgof supernatant
(diluted to 1 ml with lysis buffer) and 40 l of anti-Flag M2 affinity gel
suspension (A2220; Sigma), according to themanufacturer’s instructions.
Precipitated samples were eluted with 20 l SDS-PAGE loading buffer
and then tested by Western blotting using anti-Myc rabbit MAb (2278,
1:1,000 dilution; Cell Signaling).
Protein data accession number. The atomic coordinates and diffrac-
tion data obtained in this work have been deposited in the RCSB Protein
Data Bank under accession code 4M4X.
RESULTS
Overall structure of AHR PAS-A domain and its relationship to
other PAS domains. The mouse AHR PAS-A domain protein
(residues 110 to 267) (Fig. 1A) was obtained using recombinant E.
coli expression, and crystals were generated that diffracted to a
2.55-Å resolution. We solved the structure using molecular re-
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FIG 1 The overall structure of the mouse AHR PAS-A domain. (A) Schematic representation of domain compositions of the AHR and ARNT proteins. (B)
Comparison of dimer interfaces of PAS-A and PAS-B domains from bHLH-PAS proteins. The AHR PAS-A domain dimer has an A=-helix-swapped interface,
similar to that of themouseCLOCK:BMAL1PAS-A dimer (21). The humanHIF-2:ARNTPAS-B dimer exhibits an antiparallel-sheet interface (19), while the
mouse CLOCK:BMAL1 PAS-B domains dimerize in a roughly parallel fashion (21). (C) Sequence alignment of PAS-A domains of mouse AHR and ARNT.
Secondary structure elements are labeled above the alignment, and conserved residues are indicated by asterisks. AHR residuesmutated in the functional studies
are highlighted in green, and those ARNT residues thatmay be involved in heterodimer interaction are colored in yellow. (D) Three-dimensional structure of the
AHRPAS-A domainwith secondary structure elements labeled fromN-terminal A= to the canonical PAS fold in an alphabetical progression, with color ramped
from blue to red. (E) Superimposition of PAS fold regions of AHR (green), CLOCK (magenta), and BMAL1 (orange) shows different orientations of the
N-terminal A=-helices. (F) Comparison of the AHR homodimer structure with that of the CLOCK:BMAL1 PAS-A dimer by superimposing one monomer of
AHR with CLOCK.
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placement with a combined template consisting of three PAS-A
structures, one derived from the Bacillus subtilis histidine protein
kinase KinA (27) and two from the Drosophila PER protein (28,
29). The data collection and refinement statistics are summarized
in Table 1. The crystal asymmetric unit contained two AHRmol-
ecules arranged as a homodimer, as shown in Fig. 1B. Consistent
with the expected PAS fold (1), the AHR PAS-A subunit forms a
five-stranded antiparallel -sheet with the topological strand or-
der B-A-I-H-G, with four accompanying -helices (C, D, E,
and F) flanking one side of the -sheet (see Fig. 1C and D).
Located along theN terminus of theAHRPAS-Adomain, a key
-helical structure (denoted as A=) corresponding to residues
110 to 119 is seen to form a helix-swapped dimer interface with its
counterpart from the second subunit (Fig. 1B and C). In addition
to the helix-helix interaction, this A=-helix also interacts across
the dimer interface with a portion of the -sheet from the second
subunit. The CLOCK:BMAL1 (21) PAS-A dimer shown in Fig. 1B
utilizes a similar overall type of interaction involving the swapped
A=-helices as the central bridging unit. A closer look at these two
related PAS-A dimers reveals that the orientation of the A=-helix
of the AHR is slightly different from that seen in the CLOCK:
BMAL1 complex (Fig. 1E). The seemingly looser interactions in
the CLOCK:BMAL1 dimer interface may be due to an adjustment
in that interface required for accommodating the adjacent bHLH
and PAS-B dimer interfaces in the same heterodimer (Fig. 1F).
We find that PAS-B dimer interfaces, such as those from HIF-
2:ARNT (19) and CLOCK:BMAL1 (21) complexes, are quite
distinct from the PAS-A dimer interfaces we describe here for
AHR and that are seen with the CLOCK:BMAL1 heterodimer, as
displayed in Fig. 1B. Mammalian PAS-B domains dimerize in a
variety of distinct fashions using different interfaces, and these
variations may allow these domains to accommodate the other
physical and functional requirements of their full-length polypep-
tides, in some cases also allowing these domains to bind to other
types of proteins or small-molecule ligands (2).
Functional importance of the N-terminal A=-helix.We had
not anticipated that the AHR PAS-A domain would show a ho-
modimeric form in the crystal, since full-lengthAHRhadnot been
previously observed as a functional homodimer (1, 22, 33). There-
fore, we explored the possibility that homodimerization of the
AHR PAS-A domain is due simply to crystal packing. To study its
oligomeric state, we analyzed the solution size of this protein using
gel filtration chromatography (Fig. 2A). The mAHR PAS-A pro-
tein (residues 110 to 267, WT) has a calculated molecular mass of
21 kDa including the His tag yet shows a single peak with a reten-
tion volume of 87.0ml (corresponding to a size of 37 kDa, approx-
imately) when loaded on the column at a concentration of 120
M, indicating that it behaves entirely as a homodimer in solu-
tion. Furthermore, several diluted samples with concentrations of
80 M, 16 M, and 8 M all displayed similarly positioned gel
filtration peaks, as shown in Fig. 2A. This finding suggests that
even at a protein concentration as low as 8 M, the AHR PAS-A
domain behaves as a dimer in solution.
The close relationship of the AHR dimer interface in our crys-
tal structure, with the CLOCK:BMAL1 dimer interface previously
reported, further supports the notion that the structurally ob-
served arrangement in our crystals is not simply an artifact of
crystal packing. To further test whether the A=-helix-connected
dimer interface is important for homodimer formation, as sug-
gested by the crystal structure, we recombinantly produced and
purified a A= mutant (mAHR 120–167, molecular weight of
nearly 20 kDa with the His tag) and found this protein to elute
with a gel filtration retention volume of 98.1ml (corresponding to
about 17 kDa size). This finding confirms that without the A=-
helix acting as the critical dimerization component, the AHR
PAS-A domain will behave as a monomer.
Next, to examine whether the A=-helix is also important for
the transcriptional activity of the AHR full-length protein, we
used theXRE luciferase reporter assay shown in Fig. 2B. A deletion
of the A=-helix from the full-length AHR protein caused a dra-
matic decrease in the transcriptional activity of this mutant
(A=) compared with that of WT AHR in both the absence and
presence of the small-molecule ligand TCDD. This finding was
consistent when using both AHR-deficientmurine hepatoma Tao
cells and HEK 293T cells (Fig. 2B).
AHR is known to functionmainly as a heterodimerwithARNT
in vivo. Since the A=-helix appears to be required for the
dimerization and the transcriptional activity of AHR, we asked
whether a similar dimerization interface would allow the PAS-A
elements of AHR and ARNT to interact effectively in a het-
erodimer. These two proteins also contain bHLH and PAS-B do-
mains, and each of these separate domains can, in principle, give
rise to other dimerization junctions in their heterodimer. We
cotransfected full-length AHR and ARNT into 293T cells and as-
sessed by co-IP if these proteins could interact efficiently when
only the A=-helix of AHR was deleted (Fig. 2C). Removal of this
helix caused a severe loss in the ability of full-length AHR and
ARNT to coassociate in cells. This finding suggests that the AHR
TABLE 1 Data collection and refinement statisticsa




a, b, c (Å) 88.17, 88.17, 110.01
, ,  (°) 90, 90, 90
Resolution (Å) 68.8–2.55 (2.59–2.55)
Rmerge 0.070 (0.837)
I/I 31.83 (2.54)
Completeness (%) 99.57 (99.30)
Redundancy 9.1 (8.1)
Refinement
Resolution (Å) 33.9–2.55 (2.64–2.55)









Bond lengths (Å) 0.006




a The data were obtained from a single crystal.
b Values in parentheses are for the highest-resolution shell.
c Root mean square deviations.
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PAS-A homodimerization determinants are also required for
AHR:ARNT heterodimerization.
We also tested biochemically the ability of E. coli coexpressed
AHR and ARNT proteins to associate as a heterodimer in an AHR
A=-helix-dependent manner. Here we used the mAHR 7–267
region and themARNT 82–346 region, which contain in each case
both their bHLH and PAS-A domains (Fig. 1A). As shown in the
SDS-PAGE gel of Fig. 2D, ARNT and AHR copurified from a
Ni-nitrilotriacetic acid (NTA) column when only AHR contained
a His tag (located at its N terminus). The copurification was not
possible when theA=mutant of AHRwas used (Fig. 2D). These
biochemical findings are fully consistent with our cell-based co-IP
results shown in Fig. 2C. Taken together, the transactivation
study, the cell-based co-IP study, and the biochemical coassembly
experiment all consistently point to the A=-helix being an essen-
tial segment used for AHR’s heterodimerization interface with
ARNT. While our studies leave open the possibility of PAS-B or
bHLH dimerization junctions also being critical in this het-
erodimer, they do suggest that these other dimerization surfaces,
on their own andwithout the PAS-A interface, are not sufficient to
ensure the productive formation of the functional AHR:ARNT
heterodimer.
Effect of pointmutations atAHRdimerization interface.The
interactions at the AHR PAS-A dimer interface involve two dis-
tinct regions, both of which involve the participation of the A=-
helix (Fig. 3A). The first region forms between the two reciprocat-
ing A=-helices and consists of hydrophobic interactions between
Leu110, Leu117, Ala119, and Leu120. The second one involves the
A=-helix forming contacts with the -sheet of the other subunit
and includes the hydrophobic residues Phe115, Leu116, Ala119
(A=), Val124 (A), Phe260, Ile262 (I), and a set of polar resi-
dues, Ser108, Glu112, Gln118 (A=), Arg236, Lys238 (H), and
His241 (HI loop), as shown in Fig. 3A. Ala119 appears to be crit-
ically important, since it is involved in both of these dimerization
junctions simultaneously and together with Leu120 maps to the
center of the dimer interface (Fig. 3B).
In the previous section, we examined the overall importance of
the A=-helix through its entire deletion. To examine the relative
contribution of each specific residue for the dimerization proper-
ties of AHR, we made point mutants using mAHR 110 to 267 as
the template and analyzed the dimerization abilities of these mu-
tated AHR proteins by gel filtration chromatography profiling
(mutants of Phe260 or Ile262 were not included due to their in-
solubility). As shown in Fig. 4A, all the AHR mutants, except the
E112A mutant (85.6 ml), displayed increased retention volumes
compared to that of wild-type AHR (87.4 ml). Mutants with a
peak position after 91 ml were the F115A (91.4 ml), F115D (91.7
ml), L116E (91.9 ml), A119D (91.8 ml), L120E (91.9 ml), V124D
(91.2 ml), F115D/L116E (91.4 ml), and L117E/A119D/L120E
(91.3 ml) mutants. Therefore, these point mutations appear to
highly disrupt the dimerization ability of AHR, confirming that
the crystallographically observed residues, shown in Fig. 3A, are
critical for the dimerization of AHR.
We next examined the contribution from each of these inter-
facial residues in the context of the full-length AHR protein’s
ability to activate transcription and form heterodimeric inter-
action with ARNT. For these studies, we employed the XRE
reporter assay and the co-IP assay, as described above. We
found that mutants carrying the E112A, L116E, A119D, L120E,
V124D, F260D, I262D, F115D/L116E, L117E/A119D/L120E,
FIG 2 TheA=-helix of the PAS-A domain is essential for AHRdimerization and function. (A)Gel filtration chromatography of the AHRwild-type protein (110
to 267) and theA=mutant (120 to 267), as well as themarker proteins albumin (66 kDa), carbonic anhydrase (29 kDa), and cytochrome c (12.4 kDa). (B) XRE
luciferase reporter assay examining the effect of A=-helix deletion on the transactivation of full-lengthAHR in bothTao and 293T cells in the presence or absence
of ligand TCDD (10 nM). Error bars (SD) are derived from three experiments. (C) Co-IP experiments showing the effects of A=-helix deletion on association
of AHR and ARNTwith or without TCDD (10 nM) treatment. (D) Ni affinity pulldown assay assessing the interactions between coexpressed AHR (wild type or
A=mutant) and ARNT proteins, both of which include bHLH and PAS-A domains.
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and V124D/F262D/I262D changes showed luciferase activities
that were reduced from that of wild-type AHR in both Tao and
293T cells (Fig. 4B). This loss of activity was correlated with a
reduced ability of these AHR mutants to interact physically
with the ARNT protein (Fig. 4C). These results together point
to a set of six hydrophobic residues in AHR: Leu116, Ala119,
Leu120 (A=), Val124 (A), Phe260, and Ile262 (I), being
required for maintaining the overall integrity of the AHR:
ARNT heterodimer and its transcriptional activity (Fig. 3A).
Near the C terminus of A=-helix of AHR, besides Leu116,
Ala119, and Leu120, there are two other hydrophobic residues,
Phe115 (corresponding to Leu113 of CLOCK or Leu150 of
BMAL1) (21) and Leu117, also involved in dimerization (Fig. 3A).
But single mutations of these two residues could not totally abol-
ish the transactivation anddimerization properties of AHR:ARNT
(Fig. 4) or CLOCK:BMAL1 (21), suggesting that they may not be
as significant contributors to heterodimerization as the other six
residues identified above.
Dimerization determinants for the PAS-A domains ofmam-
malian bHLH-PAS proteins. The above mutational studies
strongly suggest that the amino acid determinants of AHR PAS-A
homodimerization are similarly used for heterodimerization with
ARNT. To better understand how the AHR:ARNT interface is
likely to form through their PAS-A domains in a manner that is
also consistent with our mutational data, we built a homology
model of the mouse ARNT PAS-A domain by using the SWISS-
MODEL server (34) with the BMAL1 structure (21) as the tem-
plate. We then docked this ARNT PAS-A model in a position
identical to that of one of the two AHR subunits in our crystal
structure. As shown in Fig. 5A, all six AHR residues confirmed
mutationally are able to mediate similar productive interactions
with their amino acid counterparts in ARNT. The six reciprocal
residues in ARNT (Ile168, Ala171, Ala172, Leu176, Val338, and
Ile340; see Fig. 1C) are similarly hydrophobic and are well posi-
tioned to form stabilizing contacts in a way similar to that seen in
the AHR homodimer (Fig. 5A). This model of AHR-ARNT inter-
actions uses equivalent PAS-A regions in these two proteins for
dimerization, as proposed by Hao et al. (22).
The model of AHR:ARNT we constructed also provides a use-
ful template for interpreting the mutational data previously de-
scribed by others. For example, we found that mutation of AHR
residue Glu112 showed an effect on dimerization very similar to
that of a mutation on ARNT residue Glu163 (22) (Fig. 1C). Both
mutations disrupt heterodimerization, while leading in each case
to preferential homodimer formation (22) (Fig. 4), suggesting
they may be involved in determining specificity of dimerization.
Another mutation, G341D, was reported to be responsible for the
defective function of ARNT in Hepa-1 c4 cells (35). In our model
(Fig. 5A), Gly341 locates near the end of the I-strand, and its
substitution by aspartate would suggest amarked reduction in the
stability of the -sheet and a further loss of dimerization by mis-
orienting Ile340. Ile340 corresponds to Ile262 of AHR (Fig. 4) and
Ile317 of BMAL1 (21), both of which have been shown to be crit-
ical for dimerization. The two-hybrid study by Hao et al. also
identified the ARNTmutationA339D (22) (it locates between two
interface residues, Val338 and Ile340, in our model) to be critical
for the heterodimerization of ARNT and AHR and for their tran-
scriptional activity. In contrast, the mutation I340V, which mod-
estly changes the hydrophobic side chain, only slightly weakens
FIG 3 The details of the AHR PAS-A homodimer interface. (A) The interface is composed of two regions: between the two A=-helices (top) and between one
A=-helix and the -sheet (bottom). The interfacial residues are labeled and shown in sticks. Hydrogen bonds are indicated as yellow dashed lines, and water
molecules are indicated as red dots. The secondary structure elements are labeled. (B) Ala119 and Leu120 locate at the central position of the AHR PAS-A dimer
interface. The upper part is 180 degrees rotated from the AHR structure shown in panel A, with Ala119 and Leu120 colored in red. The lower one is a stereo image
showing the detailed conformations of Ala119, Leu120, and residues around them in an electron density map (2Fo-Fc map contoured at 1.2 ).
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the heterodimerization of these proteins and does not change
their transcriptional activity (22).
To further investigate the importance of the ARNT A=-helix
in the AHR:ARNTPAS-A interface, we selected four hydrophobic
residues (Leu167, Ile168, Leu169, and Ala171) at the C terminus
of the A=-helix for mutational studies. As shown by the XRE
reporter assay in Fig. 5B, the luciferase activities of three full-
length ARNT mutants carrying L167E, I168D, and A171D were
reduced from that of the wild type in both the absence and pres-
ence of TCDD. This finding agrees with results of the co-IP exper-
iment we also carried out, which showed total lost or weakened
interactions between AHR and these ARNT mutants (Fig. 5C).
These studies highlight the importance of Leu167, Ile168, and
Ala171 in mediating the transactivation and dimerization of the
AHR:ARNT complex. Interestingly, the other ARNT mutation,
L169E, decreased neither the XRE luciferase activity nor the bind-
ing to AHR (Fig. 5B and C), similar to the corresponding AHR
mutation L117E (Fig. 4B and C). We find that all of our experi-
mental data, as well as the data from the previous published stud-
ies, correlate well with the AHR:ARNT PAS-A dimer model
shown in Fig. 5A, suggesting its validity.
We next compared our AHR:ARNT model with the CLOCK:
BMAL1 PAS-A complex (21) and noted that the six correspond-
ing interfacial residues in CLOCK (Met114, Ala117, Leu118,
Phe122, Val252, and Thr254) and those in BMAL1 (Ile151,
Ala154, Ala155, Leu159, Val315, and Ile317) were also involved in
the PAS-A heterodimer interface, along with several additional
hydrophobic residues (Fig. 5D). Most of these interfacial contact
residues locate either near the N terminus of the PAS-A domain
(A= and A) or near its C terminus (I). This manner of residue
localization may make it possible to coordinate the dimerization
of PAS-A domains with the dimerization requirements of bHLH
domains at the immediate N-terminal side, and that of the PAS-B
domains at the immediate C-terminal side of the PAS-A domains,
in the context of full-length proteins.
To more broadly relate the residues used by the AHR PAS-A
domain for dimerization to other mammalian bHLH-PAS pro-
teins, we aligned the set of protein sequences shown in Fig. 5E. The
six key hydrophobic residues important for AHRdimerization are
not absolutely conserved in this family, but their residue counter-
parts (colored in red) are still mainly hydrophobic residues. This
finding is consistent with our expectation that the amino acid
distinctions at these six sites may render different binding affini-
ties for pairwise heterodimerization within this family. Moreover,
based on the amino acid sequences at the C terminus of A=,
corresponding to AHRAla119 and Leu120, these bHLH-PAS pro-
teins can be divided into three groups, which also correspond to
the functional subclasses of this family (i.e., Ala-Leu for class I
FIG4 Identification of the contact residues important for dimerization and function of AHR. (A)Gel filtration chromatography of wild-type (WT) andmutated
mAHR 110–267 proteins. The same column and protein markers are used as in Fig. 2A. (B) XRE luciferase reporter assay evaluating the effects of mutations on
transactivation of full-length AHR in both Tao and 293T cells, with or without TCDD (10 nM) treatment. All error bars (SD) are derived from three samples. (C)
Co-IP experiments showing the effects of mutations on the interaction between AHR and ARNT promoted by TCDD (10 nM).
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transcriptional activators, [Thr/Ser]-Leu for class I transcriptional
repressors, and Ala-Ala for class II general partners) (Fig. 5E).
Given the central positions of these two residues at the dimer
interface (Fig. 3B), they may be especially important components
of partner recognition in this family.
Several related PAS proteins appear to deviate significantly
from our suggested model of PAS-A dimerization. The IPAS (in-
hibitory PAS domain) protein is a spliced variant of HIF-3, and
it dimerizes with HIF-1 but not ARNT (36). We noticed that
compared with HIF-3, IPAS has the same sequence in the bHLH
domain and the C-terminal region of the PAS-A domain but a
totally changed sequence in the N-terminal region of PAS-A, in-
cluding the A=-helix and A-strand (Fig. 5E). Thus, the lack of
the A=-helix could be one reason why IPAS has no ability to bind
FIG 5 Comparison of PAS-A domains from mouse bHLH-PAS proteins. (A) Homology model of mouse ARNT PAS-A domain forming a heterodimer with
AHR. The interactions at the dimer interface are illustrated in three regions: between two A=-helices (top right), ARNT A=-helix and AHR -sheet (bottom
left), and AHR A=-helix and ARNT -sheet (bottom right). The residues involved in the dimer interface are shown in sticks and annotated. The secondary
structure elements are also labeled. (B) Luciferase reporter assay testing the effects of point mutations of full-length ARNT on XRE transactivation in 293T cells,
with or without TCDD (10 nM) treatment. (C) Co-IP experiments showing the effects of ARNT mutations on the interaction between AHR and ARNT in the
presence of TCDD (10 nM). (D) Reanalysis of mouse CLOCK:BMAL1 PAS-A dimer interface (21) by showing the interactions in three regions: between two
A=-helices (top right), BMAL1 A=-helix and CLOCK -sheet (bottom left), and CLOCKA=-helix and BMAL1 -sheet (bottom right). Interface residues are
shown in sticks and labeled. (E)Multiple sequence alignment ofmember proteins from themouse bHLH-PAS family and some related proteins. Only the regions
near the N-terminal (A=-helix and A-strand) or C-terminal (I-strand) regions of the PAS-A domain are aligned. Secondary structure elements are labeled
above the alignment, and fully conserved residues are indicated by asterisks. Six hydrophobic residues identified as important for AHR dimerization and their
corresponding residues in other bHLH-PAS proteins are colored in red. Residues corresponding to Phe115 and Leu117 of AHR are colored in blue. The central
interface residues (counterparts of AHR Ala119 and Leu120) are boxed.
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to ARNT, instead binding to HIF-1 in a presumably unrelated
way. Mammalian PERs (PER1, PER2, and PER3) also have tan-
dem PAS domains near the N terminus but have no bHLH do-
mains. The crystal structure of themouse PER2 fragment (includ-
ing PAS-A, PAS-B domains, and the E-helix at the C terminus)
revealed a homodimeric interface mediated mainly by the PAS-B
-sheet in an antiparallel orientation, complemented by interac-
tions of the PAS-A domain with PAS-B and the E-helix (29).
Interestingly, in this structure, the short extension N-terminal to
the PAS-A domain (corresponding to the A=-helix region of
AHR) does not form a helix but instead forms turns and has an
amino acid sequence altogether different from those of the PAS-A
domains of the bHLH-PAS family (Fig. 5E). Without the A=-
helix, it is not surprising that PER2 homodimerizes in a dramati-
cally different way from the bHLH-PAS proteins.
DISCUSSION
Based on studies of both mammalian and nonmammalian PAS-A
domains, we believe that the formation of homodimers or het-
erodimers can arise using three modes of interaction. The first
mode is represented by the PAS-A domain ofB. subtilisKinA (27),
which forms the dimer interface through two -sheets (Fig. 6A).
Interestingly, in this KinA crystal, there are two types of dimers
using the same -sheet interface while differing in their buried
surface areas and packing angles (27). The second dimerization
mode requires only -helices (N- or C-terminal to the core PAS
fold) for the interface, as seen in the PAS-A structure of Klebsiella
pneumoniae sensor histidine kinase CitA (37). The third mode of
PAS-A dimerization involves both -sheets and terminal -heli-
ces. The A=-helix-swapped interface seen in the PAS-A domains
of AHR and the CLOCK:BMAL1 complex (21) is also used by
some prokaryotic proteins. For example, PAS-A domains of the
nitrogen fixation negative regulator NifL (38) from Azotobacter
vinelandii and the redox sensor DOS (39) from E. coli both form
relatively similar interfaces involving A=-helices and -sheets
(Fig. 6A). However, the positions of their A=-helices (Fig. 6B)
and the sequences of their interface residues (Fig. 6C) are some-
what different from those of AHR and CLOCK:BMAL1. In addi-
tion, some prokaryotic proteins with only one PAS domain also
use both -sheets and terminal -helices to form diverse dimer
interfaces, such as those seen with the sensor histidine kinase FixL
(40) from Sinorhizobiummeliloti, the signal transduction histidine
kinase STHK (41) from Nostoc punctiforme, and the methyl-ac-
cepting chemotaxis protein GSU0935 (42) from Geobacter sul-
furreducens (Fig. 6A).
Except for NPAS2, which binds to heme with both PAS do-
FIG 6 Dimerization properties of PAS-A domains. (A) Three dimerizationmodes:-sheet/-sheet (/)mode, represented by B. subtilisKinA;-helix/-helix
(/)mode, represented byK. pneumoniaeCitA; and-helix/-sheet (/)mode, represented byA. vinelandiiNifL, E. coliDOS, S. meliloti FixL,N. punctiforme
STHK, and G. sulfurreducens GSU0935. (B) The orientations and positions of the A=-helices at the PAS-A dimer interfaces of A. vinelandii NifL, E. coli DOS,
mouse AHR, and mouse CLOCK:BMAL1 complex. (C) Structure-based sequence alignment of NifL, DOS, AHR, CLOCK, and BMAL1 PAS-A domains. The
secondary structure elements are indicated above sequences according to that of NifL (-helix is indicated by “h’s,” and -strand is indicated by “e’s”). The
interface residues of NifL and DOS are colored orange, while those of AHR, CLOCK, and BMAL1 are red or blue, as shown in Fig. 5E.
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mains and functions as a gas-responsive transcription factor (43),
the PAS-A domains of most mammalian bHLH-PAS proteins
have not been reported to bind small-molecule ligands (2).Mean-
while many other proteins containing multiple PAS domains,
such as mouse PER2 (heme) (44) and the prokaryotic proteins
CitA (citrate) (37), NifL (FAD) (38), and DOS (heme) (39), use
their PAS-A domains for cofactor binding (Fig. 7). Despite the
wide diversity of these ligands, the binding pockets of PAS do-
mains are spatially conserved and are formed by the inner surface
of the-sheet andhelices E and F (1) (Fig. 1D).However, in the
PAS-A structures of AHR we describe here and in CLOCK and
BMAL1 PAS-A domains, this cavity appears to be filled by mainly
hydrophobic residues, occluding their surfaces and preventing the
binding of hydrophobic ligands (Fig. 7). The PAS-B domain, in-
stead of PAS-A, in AHR has been shown to be the site of binding
for small molecules, including TCDD (4, 45).
In summary, we find that PAS-A domains of the mammalian
bHLH-PAS proteins AHR:ARNT and CLOCK:BMAL1 dimerize
in a similar way, with the A=-helix-swapped interface mediated
mainly by hydrophobic residues. Based on our protein amino acid
sequence analysis, we anticipate that other mammalian bHLH-
PAS proteins may dimerize in a very similar manner, utilizing
similarly positioned amino acids and secondary structure ele-
ments within their PAS-A domains. Their distinctions of the two-
residue sequencewe identify at theC terminus of theA=-helix for
different subclasses, together with other unique residues at their
dimeric interface, are likely to be involved in setting their selective
patterns of dimerization. Besides the PAS-A domain, the bHLH
and PAS-B domains in the family are also expected to participate
in the overall heterodimerization patterns of these bHLH-PAS
proteins. Other mechanisms controlling the protein level (e.g.,
oxygen-dependent degradation of HIFs) (2), location (nuclear lo-
calization), and timing (negative feedback) further regulate the
gene transcriptional activities of bHLH-PAS proteins, probably by
controlling their interactions with specific transcriptional coregu-
lators.
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